No Data
No Data
Kelly Thai (300326.SZ): Net profit of 10.87.65 million yuan in the first quarter decreased by 85.48% year on year
On April 23, Ge Longhui (300326.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 246 million yuan, down 16.37% year on year; net profit attributable to shareholders of listed companies was 10.8765 million yuan, down 85.48% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 8.316 million yuan, down 82.13% year on year; basic earnings per share were 0.0152 yuan.
Kelly Thai (300326.SZ) announced its 2023 annual results, turning a loss into a profit of 113 million yuan
Kellitai (300326.SZ) released its 2023 annual report. The company's revenue was 956 million yuan,...
Kellitai (300326.SZ): Holding company Jienuo Medical plans to introduce employee shareholding platform
Kellitai (300326.SZ) announced that in order to further mobilize the subsidiary Jienuo Medical Management Group Co., Ltd. (“Jie...
Kellitai (300326.SZ): The subsidiary's import registration certificate for disposable bipolar radiofrequency surgical electrode kit products was approved
On March 29, Gelonghui (300326.SZ) announced that its wholly-owned subsidiary Elliquence, LLC recently obtained a Class II “Medical Device Registration Certificate” for the import of disposable bipolar radiofrequency surgical electrode sets issued by the China Drug Administration. The product has been reviewed, complies with medical device market entry requirements, and registration is permitted. It is valid until March 7, 2019. The disposable bipolar radiofrequency surgical electrode kit consists of a bipolar radiofrequency surgical electrode, a depth control valve, a guide needle, a straight working cannula, an oblique working cannula, a conical expander, and a ring drill. Product and our high-frequency hand
Kelly Thai (300326.SZ): Net profit for the first quarter fell 83.98%-89.32%
Gelonghui, March 18 | Kellytech (300326.SZ) announced its results forecast for the first quarter of 2024. Net profit attributable to shareholders of listed companies during the reporting period was 8 million yuan to 12 million yuan, a decrease of 83.98%-89.32% from the same period last year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 7 million yuan to 10.5 million yuan, a decrease of 77.42%-84.95% over the same period last year. During the reporting period, the estimated net profit range of the company attributable to shareholders of listed companies was 8 million yuan to 12 million yuan, down 8 from the same period last year
Benign Growth For Shanghai Kinetic Medical Co., Ltd (SZSE:300326) Underpins Stock's 26% Plummet
Shanghai Kinetic Medical Co., Ltd (SZSE:300326) shareholders that were waiting for something to happen have been dealt a blow with a 26% share price drop in the last month. Instead of being rewarde
No Data